The global market for Artificial Skin Substitute was valued at US$ 1152 million in the year 2024 and is projected to reach a revised size of US$ 2276 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Artificial Skin Substitutes are a heterogeneous group of biologic, synthetic, or biosynthetic materials that can provide temporary or permanent coverage of open skin wounds. Skin substitutes ideally possess the composition and function of skin or have the potential for autologous regenerative healing when applied to a wound.
As the technology of Artificial Skin Substitutes is not relatively mature, the downstream market, especially for Chronic Wounds market is growing fast, there are a lot of enterprises in the Artificial Skin Substitutes market. The Artificial Skin Substitutes market competition will be still intense. Integra LifeSciences, Smith & Nephew, Organogenesis, Allergan and MiMedx is the leading manufacturer in the Artificial Skin Substitutes market. The top 5 listed companies accounted for 60% of the market share in terms of revenue.
Market development trends and prospects
Technological innovation:
With the continuous development of materials science, biotechnology and intelligent manufacturing, artificial skin substitutes will become more intelligent, personalized and customized.
The continuous emergence of new biomaterials, synthetic materials and biocomposites will inject new vitality into the market.
Market expansion:
In addition to traditional medical and beauty fields, artificial skin substitutes will also expand to consumer electronics, robotics and other fields.
The further development of the international market and the enhancement of brand influence will promote the increase in the export volume of Chinese artificial skin products.
Policy support:
The government's continuous strengthening of supervision of the medical device industry and the improvement of supervision of emerging formats such as medical beauty will provide strong guarantees for the healthy development of the market.
The support and promotion of industrial policies will promote the rapid development of the artificial skin substitute industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Skin Substitute, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Skin Substitute.
The Artificial Skin Substitute market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Skin Substitute market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Skin Substitute manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Integra LifeSciences
Gunze Medical
Medskin Suwelack
´¡²Ô¾±°ì²¹Ìý°Õ³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ
Symatese Group
Smith & Nephew
Allergan
Tissue Regenix
Organogenesis
Mylan
Medtronic
MiMedx
Mallinckrodt
Unitrump Bio
Segment by Type
Bilayer
Dermal
Epidermal
Segment by Application
Chronic Wound
Burns Wound
Surgical Wound
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Skin Substitute manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Skin Substitute in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Artificial Skin Substitute Market Overview
1.1 Product Definition
1.2 Artificial Skin Substitute by Type
1.2.1 Global Artificial Skin Substitute Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bilayer
1.2.3 Dermal
1.2.4 Epidermal
1.3 Artificial Skin Substitute by Application
1.3.1 Global Artificial Skin Substitute Market Value by Application (2024 VS 2031)
1.3.2 Chronic Wound
1.3.3 Burns Wound
1.3.4 Surgical Wound
1.3.5 Others
1.4 Global Artificial Skin Substitute Market Size Estimates and Forecasts
1.4.1 Global Artificial Skin Substitute Revenue 2020-2031
1.4.2 Global Artificial Skin Substitute Sales 2020-2031
1.4.3 Global Artificial Skin Substitute Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Artificial Skin Substitute Market Competition by Manufacturers
2.1 Global Artificial Skin Substitute Sales Market Share by Manufacturers (2020-2025)
2.2 Global Artificial Skin Substitute Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Artificial Skin Substitute Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Artificial Skin Substitute, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Skin Substitute, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Skin Substitute, Product Type & Application
2.7 Global Key Manufacturers of Artificial Skin Substitute, Date of Enter into This Industry
2.8 Global Artificial Skin Substitute Market Competitive Situation and Trends
2.8.1 Global Artificial Skin Substitute Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Artificial Skin Substitute Players Market Share by Revenue
2.8.3 Global Artificial Skin Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Artificial Skin Substitute Market Scenario by Region
3.1 Global Artificial Skin Substitute Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Artificial Skin Substitute Sales by Region: 2020-2031
3.2.1 Global Artificial Skin Substitute Sales by Region: 2020-2025
3.2.2 Global Artificial Skin Substitute Sales by Region: 2026-2031
3.3 Global Artificial Skin Substitute Revenue by Region: 2020-2031
3.3.1 Global Artificial Skin Substitute Revenue by Region: 2020-2025
3.3.2 Global Artificial Skin Substitute Revenue by Region: 2026-2031
3.4 North America Artificial Skin Substitute Market Facts & Figures by Country
3.4.1 North America Artificial Skin Substitute Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Artificial Skin Substitute Sales by Country (2020-2031)
3.4.3 North America Artificial Skin Substitute Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Artificial Skin Substitute Market Facts & Figures by Country
3.5.1 Europe Artificial Skin Substitute Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Artificial Skin Substitute Sales by Country (2020-2031)
3.5.3 Europe Artificial Skin Substitute Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Skin Substitute Market Facts & Figures by Region
3.6.1 Asia Pacific Artificial Skin Substitute Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Artificial Skin Substitute Sales by Region (2020-2031)
3.6.3 Asia Pacific Artificial Skin Substitute Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Artificial Skin Substitute Market Facts & Figures by Country
3.7.1 Latin America Artificial Skin Substitute Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Artificial Skin Substitute Sales by Country (2020-2031)
3.7.3 Latin America Artificial Skin Substitute Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Skin Substitute Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Skin Substitute Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Artificial Skin Substitute Sales by Country (2020-2031)
3.8.3 Middle East and Africa Artificial Skin Substitute Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Skin Substitute Sales by Type (2020-2031)
4.1.1 Global Artificial Skin Substitute Sales by Type (2020-2025)
4.1.2 Global Artificial Skin Substitute Sales by Type (2026-2031)
4.1.3 Global Artificial Skin Substitute Sales Market Share by Type (2020-2031)
4.2 Global Artificial Skin Substitute Revenue by Type (2020-2031)
4.2.1 Global Artificial Skin Substitute Revenue by Type (2020-2025)
4.2.2 Global Artificial Skin Substitute Revenue by Type (2026-2031)
4.2.3 Global Artificial Skin Substitute Revenue Market Share by Type (2020-2031)
4.3 Global Artificial Skin Substitute Price by Type (2020-2031)
5 Segment by Application
5.1 Global Artificial Skin Substitute Sales by Application (2020-2031)
5.1.1 Global Artificial Skin Substitute Sales by Application (2020-2025)
5.1.2 Global Artificial Skin Substitute Sales by Application (2026-2031)
5.1.3 Global Artificial Skin Substitute Sales Market Share by Application (2020-2031)
5.2 Global Artificial Skin Substitute Revenue by Application (2020-2031)
5.2.1 Global Artificial Skin Substitute Revenue by Application (2020-2025)
5.2.2 Global Artificial Skin Substitute Revenue by Application (2026-2031)
5.2.3 Global Artificial Skin Substitute Revenue Market Share by Application (2020-2031)
5.3 Global Artificial Skin Substitute Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Integra LifeSciences
6.1.1 Integra LifeSciences Company Information
6.1.2 Integra LifeSciences Description and Business Overview
6.1.3 Integra LifeSciences Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Integra LifeSciences Artificial Skin Substitute Product Portfolio
6.1.5 Integra LifeSciences Recent Developments/Updates
6.2 Gunze Medical
6.2.1 Gunze Medical Company Information
6.2.2 Gunze Medical Description and Business Overview
6.2.3 Gunze Medical Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gunze Medical Artificial Skin Substitute Product Portfolio
6.2.5 Gunze Medical Recent Developments/Updates
6.3 Medskin Suwelack
6.3.1 Medskin Suwelack Company Information
6.3.2 Medskin Suwelack Description and Business Overview
6.3.3 Medskin Suwelack Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medskin Suwelack Artificial Skin Substitute Product Portfolio
6.3.5 Medskin Suwelack Recent Developments/Updates
6.4 ´¡²Ô¾±°ì²¹Ìý°Õ³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ
6.4.1 ´¡²Ô¾±°ì²¹Ìý°Õ³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ Company Information
6.4.2 ´¡²Ô¾±°ì²¹Ìý°Õ³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ Description and Business Overview
6.4.3 ´¡²Ô¾±°ì²¹Ìý°Õ³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ´¡²Ô¾±°ì²¹Ìý°Õ³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ Artificial Skin Substitute Product Portfolio
6.4.5 ´¡²Ô¾±°ì²¹Ìý°Õ³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ Recent Developments/Updates
6.5 Symatese Group
6.5.1 Symatese Group Company Information
6.5.2 Symatese Group Description and Business Overview
6.5.3 Symatese Group Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Symatese Group Artificial Skin Substitute Product Portfolio
6.5.5 Symatese Group Recent Developments/Updates
6.6 Smith & Nephew
6.6.1 Smith & Nephew Company Information
6.6.2 Smith & Nephew Description and Business Overview
6.6.3 Smith & Nephew Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Smith & Nephew Artificial Skin Substitute Product Portfolio
6.6.5 Smith & Nephew Recent Developments/Updates
6.7 Allergan
6.7.1 Allergan Company Information
6.7.2 Allergan Description and Business Overview
6.7.3 Allergan Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Allergan Artificial Skin Substitute Product Portfolio
6.7.5 Allergan Recent Developments/Updates
6.8 Tissue Regenix
6.8.1 Tissue Regenix Company Information
6.8.2 Tissue Regenix Description and Business Overview
6.8.3 Tissue Regenix Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Tissue Regenix Artificial Skin Substitute Product Portfolio
6.8.5 Tissue Regenix Recent Developments/Updates
6.9 Organogenesis
6.9.1 Organogenesis Company Information
6.9.2 Organogenesis Description and Business Overview
6.9.3 Organogenesis Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Organogenesis Artificial Skin Substitute Product Portfolio
6.9.5 Organogenesis Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Company Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mylan Artificial Skin Substitute Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Medtronic
6.11.1 Medtronic Company Information
6.11.2 Medtronic Description and Business Overview
6.11.3 Medtronic Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Medtronic Artificial Skin Substitute Product Portfolio
6.11.5 Medtronic Recent Developments/Updates
6.12 MiMedx
6.12.1 MiMedx Company Information
6.12.2 MiMedx Description and Business Overview
6.12.3 MiMedx Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.12.4 MiMedx Artificial Skin Substitute Product Portfolio
6.12.5 MiMedx Recent Developments/Updates
6.13 Mallinckrodt
6.13.1 Mallinckrodt Company Information
6.13.2 Mallinckrodt Description and Business Overview
6.13.3 Mallinckrodt Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Mallinckrodt Artificial Skin Substitute Product Portfolio
6.13.5 Mallinckrodt Recent Developments/Updates
6.14 Unitrump Bio
6.14.1 Unitrump Bio Company Information
6.14.2 Unitrump Bio Description and Business Overview
6.14.3 Unitrump Bio Artificial Skin Substitute Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Unitrump Bio Artificial Skin Substitute Product Portfolio
6.14.5 Unitrump Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Skin Substitute Industry Chain Analysis
7.2 Artificial Skin Substitute Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Skin Substitute Production Mode & Process Analysis
7.4 Artificial Skin Substitute Sales and Marketing
7.4.1 Artificial Skin Substitute Sales Channels
7.4.2 Artificial Skin Substitute Distributors
7.5 Artificial Skin Substitute Customer Analysis
8 Artificial Skin Substitute Market Dynamics
8.1 Artificial Skin Substitute Industry Trends
8.2 Artificial Skin Substitute Market Drivers
8.3 Artificial Skin Substitute Market Challenges
8.4 Artificial Skin Substitute Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Integra LifeSciences
Gunze Medical
Medskin Suwelack
´¡²Ô¾±°ì²¹Ìý°Õ³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ
Symatese Group
Smith & Nephew
Allergan
Tissue Regenix
Organogenesis
Mylan
Medtronic
MiMedx
Mallinckrodt
Unitrump Bio
Ìý
Ìý
*If Applicable.
